French Premature-Infant Intubation Cohort Described Midazolam Use Without Complete Dose or Airway Data

Written by

in

A historical birth cohort found uncommon delivery-room premedication and substantial regimen variation. It was not designed as a randomized test of midazolam safety.

The selected infants

Among 1,494 included preterm infants, seventy-six received premedication. Midazolam was the most commonly used drug among several observed regimens. Premedicated infants differed in gestational age, weight, and initial condition.

The cohort excluded some resuscitation contexts, so its findings do not describe every delivery-room emergency.

Missing process details

The authors lacked dose, route, reason for intubation, pain scores, operator experience, attempts, and detailed intubation conditions. Those omissions limit any explanation of outcome differences.

Selection may reflect both infant stability and local practice. Prescription frequency cannot establish analgesia, amnesia, or prevention of airway injury. The paper documents practice in France in 2011, not a current local rule. For a neonatal opinion, obtain the actual indication, physiological state, drug administration, and procedural course before attributing an outcome to midazolam.

Source paper

Original analysis of the supplied journal article, identified as PMC6457540.

Related research

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *